Navigation Links
VAD in Medical News

WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD

OAKLAND, Calif., Jan. 8 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT ) World Heart Corporation ("WorldHeart") announced today that it has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration ("FDA" or the "Agency") for a pivotal Bridge-to-Transpla...

Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction

...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...

Thoratec Schedules Second Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure

...Commission’s newly required Disease Specific vad Certification. In the first four months of 2009 a...ne, the hospital’s medical team performed 18 vad implants and is actively involved in several state-of-the-art vad clinical trials for both destination (or permanent...

Thoratec Announces Appointment of Paul LaViolette to Board of Directors

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Thoratec Presentation at JMP Securities Conference to be Webcast

...oratec.com . Thoratec is world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from ...

Thoratec Schedules First Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices

...ients either await a heart transplant, or for destination therapy when transplant is not a viable option. "Hahnemann sought accreditation for our vad program because we wanted to demonstrate our commitment to our patients' safety and quality care," said George Amrom, M.D ., chief medical officer of...

Artificial pump effectively backs up failing hearts

... the trial included stroke and bleeding, and the number and type of adverse events was similar to other LVADs but better than that of first-generation vad devices. Answering standardized questionnaires for patients with heart failure, they reported a significantly improved quality of life after receiv...

Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

...atec Corporation Thoratec is a leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...

More>>

VAD in Medical Technology

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

...splantation." VELCADE-Dexamethasone versus vad as Induction Treatment Prior to ASCT in Newly Diag...he VcD arm, compared with 60 percent in the vad arm (p=0.0115). -- Post-induction complete res...the VcD arm, compared with 7 percent in the vad arm (p=0.0035). -- After the first performed A...

Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial

... quietly. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its Int...

First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan

...e common enough that hospitals can now apply for accreditation as certified vad centers, an indication of their experience in implanting the devices and ta... their device. This spring, U-M became one of the first few such accredited vad centers in the nation. The DuraHeart was invented and developed by a team...

VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma

...inical trial were presented by Professor Harousseau. The VcD arm versus the vad arm showed: -- 95 percent of patients were alive at one year compared...nd on days 9 through 12 during cycles one and two only. The patients in the vad arm were treated for four 28-day cycles with vincristine at 0.4 mg/m2 on da...

New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma

...Universitario de Salamanca - Abstract #76: Oral presentation session: Sunday 9 December, 4:30 p.m. -- VELCADE Dexamethasone (VEL/D) versus vad as Induction Treatment Prior to Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma - Lead investigator: Jean-...

WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development

...evacor(TM) VAD, is being extended to the pediatric vad and then potentially to a WorldHeart minimally inv...ty-phase bridge-to-transplant study of the Levacor vad is planned to begin in late 2007 or early 2008. Wo...rotocol for the upcoming study. About the Levacor vad The Levacor is a next-generation rotary VAD. It i...

Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

...mpare VELCADE in combination with dexamethasone to vad as induction therapy prior to SCT in 480 newly dia...onse + CR (VGPR + CR) rate of 75 percent. vad showed a CR rate of 28 percent and a VGPR + CR ...ugh 12 during cycles one and two only. Patients on vad were treated for four cycles with vincristine at 0...
VAD in Biological Technology

The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System

The HeartAssist 5™ Pediatric VAD will be introduced for the first time in the U.S. at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston on Oct. 2-4. HOUSTON (Business Wire EON) September 30, 2008 -- The Modern DeBakey...

Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study

BERLIN, November 30 /PRNewswire/ -- Berlin Heart today announced the first patient enrolment in the prospective IDE study for its EXCOR(R) Paediatric VAD, a mechanical cardiac support system for critically ill Paediatric patients suffering from severe heart failure. The multi-center IDE stud...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...

Berlin Heart Inc. Receives FDA Orphan Product Development Grant

... the grant project "Safety and Efficacy of the Berlin Heart EXCOR Pediatric vad as a Bridge to Heart Transplantation." The Berlin Heart EXCOR Pediatric vad is a system for mechanical support of the heart in end-stage heart failure ...

Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)

...tile device. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its Int...

Thoratec Presentation at J.P. Morgan Conference to be Webcast

...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Reports 44 Percent Increase in Third Quarter Revenues

...cial measures. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad and HeartMate LVAS with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporati...

Thoratec Schedules Third Quarter 2008 Conference Call, Webcast

...53. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History

... passcode 4229045. Thoratec is a world leader in therapies to address advanced stage heart failure. The company's product lines include the Thoratec vad and HeartMate LVAS with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corpor...

Thoratec Announces Appointment of Steven H. Collis to Board of Directors

...ld leader in hemodynamic restoration therapy- developing products to treat cardiovascular disease. The company's product line includes the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from ...
Other Tags
(Date:7/12/2014)... injuries increase in the summer as people gather around fire ... most vulnerable to these seasonal fire hazards: children. "Young ... by putting their hands on the side of cooking grills," ... Loyola University Medical Center in Maywood, Ill., said in a ... play with fire, you get burned, is true -- ...
(Date:7/12/2014)... “After my mom’s stroke, she loss the use of her right ... of his left side. Eating became a difficult task for them ... them enjoy eating again,” said an inventor, from Fayetteville, N.C. As ... PLATE (P C H PLATE). , The PATRICIA CAROL HALL PLATE ... for individuals who suffer from stroke, experience tremors or loss of ...
(Date:7/12/2014)... With prom shopping reaching its final ... is ready to showcase its new and trendy apparels. ... evening dresses in its online shop. Additionally, it is ... these elegant gowns. According to the company’s sales manager, ... 26, 2014. , He says, “Now, worldwide clients ...
(Date:7/12/2014)... “Critical Care Therapeutics in Major ... Four-Factor PCCs and Recombinant Products to Drive Market,” ... market in the US, UK, France, Germany, Italy, ... estimation of market size for 2013, along with ... indications that are being treated using the five ...
(Date:7/12/2014)... Lake City, Utah (PRWEB) July 12, 2014 ... spotlighted two types of startups, with awards being bestowed ... new emphasis spotlighted Utah’s outstanding entrepreneur community with recognition ... proving a sustainable model with incoming revenue. , 25 ... from across the state that are under 5 years ...
Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
(Date:7/11/2014)... When researchers at the National Institute of Standards ... do their work more effectively, they often prove ... Such was the case recently for M. Lorna ... in the growing specialization of glycomics. Glycomics is ... called glycans that are attached to proteins and ...
(Date:7/11/2014)... University, Sweden, have explored two different ways that ... leading to the formation of oxygen molecules in ... the scientific journal Nature Communications . , ... synthetic catalysts for water oxidation, which are key ... direct storage of solar energy in fuels like ...
(Date:7/11/2014)... evidence that under the normal circumstances, astrocytes ... maintain neuronal environment, and exhibit therapeutic and ... disease. Previous studies have found that nerve ... chemical induction have reduced viability, which produces ... Xiaodong Yuan, Kailuan General Hospital, Hebei United ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2
Other Contents